Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection

por Bowlus, Christopher L
Publicado 2016

The immunobiology of primary sclerosing cholangitis

por Aron, Jonathan H., Bowlus, Christopher L.
Publicado 2009

Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update

por Bowlus, Christopher L., Kenney, James T., Rice, Gary, Navarro, Robert
Publicado 2016

Analysis of the IDDM Candidate Gene Prss16 in NOD and NON Mice

por Cheunsuk, Saijai, Hsu, Tom, Gershwin, M. Eric, Bowlus, Christopher L.
Publicado 2002

Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis

por Borchers, Andrea T., Shimoda, Shinji, Bowlus, Christopher, Keen, Carl L., Gershwin, M. Eric
Publicado 2009

The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population

por Toy, Elaine, Balasubramanian, Sripriya, Selmi, Carlo, Li, Chin-Shang, Bowlus, Christopher L
Publicado 2011

Electronic health record alerts enhance mass screening for chronic hepatitis B

por Chak, Eric, Li, Chin-Shang, Chen, Moon S., MacDonald, Scott, Bowlus, Christopher
Publicado 2020

Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist()

por Malik, Adnan, Kardashian, Ani A., Zakharia, Kais, Bowlus, Christopher L., Tabibian, James H.
Publicado 2019

Gene Expression by PBMC in Primary Sclerosing Cholangitis: Evidence for Dysregulation of Immune Mediated Genes

por Aoki, Christopher A., Dawson, Kevin, Kenny, Thomas P., Gershwin, M. Eric, Bowlus, Christopher L.
Publicado 2006

Human β-Defensin 2 in Primary Sclerosing Cholangitis

por Chang, Cindy, Lleo, Ana, Kananurak, Anchasa, Grizzi, Fabio, Tsuneyama, Koichi, Invernizzi, Pietro, Bevins, Charles L, Bowlus, Christopher L
Publicado 2017

Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis

por Kowdley, Kris V., Bowlus, Christopher L., Levy, Cynthia, Mayo, Marlyn J., Pratt, Daniel S., Vuppalanchi, Raj, Younossi, Zobair M.
Publicado 2023

A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale

por Levy, Cynthia, Bowlus, Christopher L., Carey, Elizabeth, Crawford, Julie M., Deane, Karen, Mayo, Marlyn J., Kim, W. Ray, Fried, Michael W.
Publicado 2018

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012

por Stewart, Susan L, Kwong, Sandy L, Bowlus, Christopher L, Nguyen, Tung T, Maxwell, Annette E, Bastani, Roshan, Chak, Eric W, Chen Jr, Moon S
Publicado 2016

Community-Based Services to Improve Testing and Linkage to Care Among Non–U.S.-Born Persons with Chronic Hepatitis B Virus Infection — Three U.S. Programs, October 2014–September 2...

por Harris, Aaron M., Link-Gelles, Ruth, Kim, Karen, Chandrasekar, Edwin, Wang, Su, Bannister, Nicole, Pong, Perry, Chak, Eric, Chen, Moon S., Bowlus, Christopher, Nelson, Noele P.
Publicado 2018

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

por Mayo, Marlyn J., Carey, Elizabeth, Smith, Helen T., Mospan, Andrea R., McLaughlin, Megan, Thompson, April, Morris, Heather L., Sandefur, Robert, Kim, W. Ray, Bowlus, Christopher, Levy, Cynthia
Publicado 2022

Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

por Mayo, Marlyn J., Carey, Elizabeth, Smith, Helen T., Mospan, Andrea R., McLaughlin, Megan, Thompson, April, Morris, Heather L., Sandefur, Robert, Kim, W. Ray, Bowlus, Christopher, Levy, Cynthia
Publicado 2023

Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis

por Liu, Bin, Yang, Guo-Xiang, Sun, Ying, Tomiyama, Takashi, Zhang, Weici, Leung, Patrick S. C., He, Xiao-Song, Dhaliwal, Sandeep, Invernizzi, Pietro, Gershwin, M. Eric, Bowlus, Christopher L.
Publicado 2022

Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis

por Trauner, Michael, Gindin, Yevgeniy, Jiang, Zhaoshi, Chung, Chuhan, Subramanian, G. Mani, Myers, Robert P., Gulamhusein, Aliya, Kowdley, Kris V., Levy, Cynthia, Goodman, Zachary, Manns, Michael P., Muir, Andrew J., Bowlus, Christopher L.
Publicado 2019

Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study

por Eksteen, Bertus, Bowlus, Christopher L., Montano‐Loza, Aldo J., Lefebvre, Eric, Fischer, Laurent, Vig, Pamela, Martins, Eduardo Bruno, Ahmad, Jawad, Yimam, Kidist K., Pockros, Paul J., Feld, Jordan J., Minuk, Gerald, Levy, Cynthia
Publicado 2020

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with p...

por Trauner, Michael, Chung, Chuhan, Sterling, Kate, Liu, Xiangyu, Lu, Xiaomin, Xu, Jun, Tempany-Afdhal, Clare, Goodman, Zachary D., Färkkilä, Martti, Tanaka, Atsushi, Trivedi, Palak, Kowdley, Kris V., Bowlus, Christopher L., Levy, Cynthia, Myers, Robert P.
Publicado 2023